chrisvoncsefalvay/vaers-outcomes huggingface dataset:
she had the Pfizer vaccine and she still got COVID; she had the Pfizer vaccine and she still got COVID; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (169752). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: COVID-19 (medically significant), DRUG INEFFECTIVE (medically significant), outcome "unknown" and all described as "she had the Pfizer vaccine and she still got COVID".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
I had soreness and rash at/near injection site but major side effect for 2nd shingles shot was sleepiness on Sunday. However, I had chills and trouble sleeping Saturday night. Very restless. I went to bed at 3 pm Sunday 12/30/2018 and could not wake up until 6:30 a.m. to use bathroom, back to bed and was able to get up at 8 a.m. Total of 17 hours sleep. Had to call off of work 12/31/2018 Monday a.m. as I was afraid to try to drive as was still dozing off.
This case was reported by a nurse and described the occurrence of therapy non-responder in a 48-year-old male patient who received ENGERIX B (batch number L5MN2, expiry date September 2016). On 29th August 2014, the patient received the 3rd dose of ENGERIX B (intramuscular) 1 ml. On 14th November 2014, 77 days after receiving ENGERIX B, the patient experienced therapy non-responder. On an unknown date, the outcome of the therapy non-responder was unknown. It was unknown if the reporter considered the therapy non-responder to be related to ENGERIX B. Additional information received: Non responder after completion of 3 doses of Hepatitis B (only certain that last dose was ENGERIX B). Titer drawn on 14 November 2014.
DX WITH COVID ON 10/15/2021; FULLY VACCINATED; PATIENT EXPIRED ON 11/06/2021
Swollen around left eye; facial swelling.  Left after observational period of 15 minutes. returned to the clinic stating mild hedache.  Symptoms had not worsened in last hour prior to re-presenting to the clinic.  Obtained oral benadryl from outpatient pharmacy.
Sore arm - 1 hour after vaccine Headache - 17 hours after vaccine Body aches, chills, fever (102), nausea - 18 hours after vaccine  Symptoms lasted 5 hours.  Mild soreness in arm next day, mild body aches, mild nausea
This spontaneous report as received from a pharmacist via field representative refers to a male patient of unknown age with no documented chicken pox or vaccination history. On an unknown date the patient was vaccinated with ZOSTAVAX (route of administration, anatomical location, lot number and expiration date and dose not reported). No concomitant medications were reported. On an unknown date, the patient experienced varicella like rash. The reporter stated that the patient went on vacation, and when he came back he had rash. Lab diagnostic studies were not reported. The reporter was unsure if treatment for varicella like rash had begun. It was reported that the patient did not recover. The reporter stated that the patient was seen in an unspecified emergency department. It was unclear whether or not the patient was admitted to the hospital. The relatedness between varicella like rash and ZOSTAVAX was not reported. Additional information has been requested.
Ten minutes after vaccine, patient began to get flushed and sweaty. Appeared pale and clammy. Lay down on cot, and symptoms resolved.
9 days of Menstration.  I'm post menopausal and haven't  had my period for 12 years.
9/22 body aches, head ache,r unny nose, cough. 9/23 numbness and tingling right hand and foot. 9/24 chest tightness, sore throat, runny nose, cough, shortness of breath, generalized weakness.
Inflammation/swelling on injection site. About 3 inches diameter on the second day, other arm felt inflamed too.
Client reports that she was feeling weird and was not a panic attack as she has had them before.  She states that she was lightheaded, dizzy and that her tongue started to well and she couldn't swallow.  Client reports that she received Benadryl, and anti nausea medication.  Client was transported to the local hospital.  Client states that she could still breath through her nose and that she was only in the ER for approximately 2.5 hours.
Patient received the Pfizer COVID-19 vaccine on 1/18/2021 and 2/9/2021 (fully vaccinated), but tested positive for COVID-19 on 9/7/2021.
This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 08-JUL-2016, the patient was vaccinated with improperly stored dose of GARDASIL (lot # M007764, expiry date: 30-JAN-2018; dose and route not reported). No adverse effects were reported. No further information provided. Additional information has been requested.
Pt given the vaccine on 3-37-06. Within 24 hrs, pt had compliants of swelling in her rt arm with redness below the injection site, numbness of her left face, tingling and numbness in her arms, headache, nausea and temperature of 101-102 degrees. Temperature on 3-30-06 was 101.3 with a red cellulitis type patch right below the injection site of the rt arm.
Systemic: Dizziness / Lightheadness-Medium, Systemic: Nausea-Medium, Additional Details: a few minutes after vaccination, pt expressed nausea and dizziness and was unable to stand due to dizziness. pharmacist assisted patient to the ground to lay down. she said she felt much better after laying down but symptoms returned after she sat back up. symptoms were on and off for about 30 minutes. pt recovered with no issues after about 30 minutes of rest
Patient at 15 minutes post vaccination stated her heart was racing and had trouble swallowing. Patient given Epinephrine 0.3 IM, Benadryl 50 MG IM, and Solumedrol 62.5 mg IM and then sent to ER.
Ended up putting the injection in the back of the left shoulder - she missed my arm muscle. I went to the doctor (I saw the dr on the 8th) and had her look at it. Immediately my mouth, nose and sinuses went numb. I had chills, fever, aches and pains - I was pretty sick for a few days but this original numbness has not gone away. The dr said to leave it alone and she thought by the weekend I would be fine but I'm still feeling the numbness.  (I had a Tetanus shot in February after I cut myself.)
PATIENT COMPLAINED OF NUMBNESS AND TINGLING IN MOUTH AND TONGUE. BENADRYL 50MG PO GIVEN.
Patient experiencing shortness of breath, on Friday 3/5 heart beating real hard, felt weak, fatigue, lasted about 15 minutes, called ems went to ed, was given prednisone, calmed down, helped with inflammation but still lethargic, chest pressure, and pain, stomach pain, feels like a weight and pressure in chest, feels like sinus infection in head, mucus in them morning was red and thick, also having night sweats
Patient was fully vaccinated.  Presented to ED on 4/24/2021 with fever of 101.8, chills, weakness, malaise/fatigue.  Pt tested and COVID-19 PCR positive.  Patient remains hospitalized
On 09-27-22, patient came in for an appointment to receive the Moderna bivalent booster. Patient was administered the Monovalent Moderna booster (NDC 80777-0275-05 dose 0.5 ml IM on the left arm). The pharmacy had just received the Moderna bivalent booster that morning and was placed in the refrigerator to be thawed out next to the other Moderna vials. The pharmacy grad intern checked in the patient and administered the vaccine, unfortunately confused the monovalent booster with the bivalent booster vial. After vaccine was administered and patient had left the pharmacy, the pharmacist looked at the vial and noticed the incorrect vaccine was administered and brought to the pharmacy grad intern's attention.   Both the pharmacist and the pharmacy grad intern referenced the CDC website for recommendations on COVID-19 vaccine administration errors and deviations, which found that the administration of a Monovalent vaccine incorrectly administered for a booster dose (if bivalent booster indicated) a patient can receive the bivalent booster after 2 months to provide protection against the Omicron variant. The pharmacy grad intern called the patient on 09-28-22 at 9:59 am and was advised of these recommendations, patient stated that she did not experience any side effects.   We are implementing a new strategy to separate the booster vials from the monovalent vaccines, also the pharmacy grad intern was coached by the pharmacist to revise her checks before administering a vaccine to a patient to ensure correct vaccine is appropriate.  On duty pharmacist is to check all vaccine vials prior to vaccination and checked for accuracy.
Tested positive for COVID-19; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (Tested positive for COVID-19) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048621A, 088D21A and 012M20A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy to chemicals (Sulfur).   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Mar-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In October 2022, the patient experienced COVID-19 (Tested positive for COVID-19). At the time of the report, COVID-19 (Tested positive for COVID-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Oct-2022, SARS-CoV-2 test: (Positive) Positive.         The patient had no acute and chronic illnesses at the time of vaccination. The patient had no other vaccines given within 1 month prior to Moderna COVID-19 vaccine. On 02-Nov-2021, the patient received the 1st booster dose of Moderna COVID-19 vaccine.  On 30-Mar-2022, the patient received the 2nd booster dose of Moderna COVID-19 vaccine. It was reported that COVID-19 symptoms began on 05/06-Oct-2022. The patient did not remember how he got it. The patient was isolated for 5 days as recommended by the  On 12-Oct-2022, patient left the house to go shopping for food with mask on. The patient had not received the treatment for COVID-19.
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE LACUNAR STROKE, UNSPECIFIED TYPE AND ARTERY ACUTE STROKE OF THALAMUS, UNSPECIFIED TYPE AND ARTERY
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and genders. The reporter stated that, on an unspecified date, an unknown number of doses of LIQUID PEDVAXHIB (dose, lot#, expiration dates not provided) that were stored at 48 degrees F for 20 minutes, then exposed to 47 degrees for 9 minutes have been administered. No adverse effects were reported.   Follow up information has been received on 22-JUL-2014 from a receptionist. The reporter stated that there were two different lot numbers of LIQUID PEDVAXHIB that were included in the temperature excursion: Lot # J016188, expiration date: 02-OCT-2016 and lot#J015437, expiration date: 09-OCT-2016. The receptionist did not have any additional information to share with Merck.  Follow up information has been received from the registered nurse who provided patients details. This report refers to a 7 months old infant patient of unknown gender. On 02-JUN-2014 the patient was vaccinated with a dose of LIQUID PEDVAXHIB (dose and route were not reported, lot#J016188, expiration date 02-OCT-2014) that was improperly stored. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information is not expected.
Post 5 minutes of receiving the vaccine patient complained of itching of throat, and felt minor throat swelling. Patient with history of allergies to ibuprofen, aspirin and other meds, and stated similar reaction. Patient  had self medicated with benadryl 25mg po, as she did not want to receive any injection. Patient observed for 30 minutes, but symptoms did not improve. We administered 25mg Benadryl IM. Patient transferred to ED for further observation.  Vital signs remained stable at the start  BP125/88, 98% on Room Air ,  HR 89 . During Transport: BP 113/74, 100% on Room Air, HR 77
Within one month of the shot, he developed headaches, dizziness, seizure, psychotic episodes, mood changes loss of consciousness. Still on going. Records reviewed Neurology consult 9/13/06 On 9/2/06 seizure suddenly for 1-2 minutes jaw opened and closed, on 9/12/06 eyes rolled back and was babbling. C/O right knee pain, right side of face feels funny, headaches last half an hour and then completely go away. Headaches located in central region and occasionally has photophobia and phonophobia along with sudden dizziness.  PMH unremarkable except for about a year ago during football he ran into a kid head first and suffered a mild concussion, no change in LOC but was nauseous and vomited for a couple of days. Some behavioral problems which started with social issues in home.   Impression: EEG is more suggestive of benign rolandic epilepsy but his seizures do not sound like being rolandic epilepsy. Neuro exam and MRI are normal. Some abnormal movements are consistent with simple motor tics and at this time does not meet criteria for Tourette's. 11/2/06-seen in ER for suicidal ideation, sensation of stabbing with knife, hallucinations, auditory and visual. Voices telling him to kill self with knives and could see and feel in stomach. Episode lasted 20 minutes with numbness to legs for 45 minutes. Patient scared as intermittent suicidal ideations and voices increasing with frequency over past 4 years.  FMH: mother recently diagnosed with depression and paternal grandmother has history sch.  DC DX: Axis I Mood disorder not otherwise specified, psychotic disorder, not otherwise specified, major depressive disorder with psychotic features, post traumatic stress disorder, rule out bipolar I disorder, most recent episode depressed with psychotic features. Neuro visit 12/6/06-abnormal movements consistent with simple motor tics. neuro exam remains norma. 4/1/2010 He is still on Lamictal to control the seizures. The pyschosis has disipated so hopefully he will be better soon.
fell down; Back pain; Disoriented; Extremely sick; Felt like pulling brain out/felt like going to die; Dizzy; Back pain; could not get up; memory was gone; This spontaneous case was reported by a consumer and describes the occurrence of DISORIENTATION (Disoriented), ILLNESS (Extremely sick), FEELING ABNORMAL (Felt like pulling brain out/felt like going to die), DIZZINESS (Dizzy) and the first episode of BACK PAIN (Back pain) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Lyme's disease, Bartonellosis (part of Lyme's disease) and Relapsing fever. Concurrent medical conditions included Allergy to antibiotic and Drug allergy (Codeine).    On 11-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced DISORIENTATION (Disoriented), ILLNESS (Extremely sick), FEELING ABNORMAL (Felt like pulling brain out/felt like going to die), DIZZINESS (Dizzy), the first episode of BACK PAIN (Back pain), HYPOKINESIA (could not get up), MEMORY IMPAIRMENT (memory was gone) and the second episode of BACK PAIN (Back pain). On 03-May-2021, the patient experienced FALL (fell down). The patient was treated with LORATADINE ongoing since an unknown date for Adverse event, at an unspecified dose and frequency. At the time of the report, DISORIENTATION (Disoriented) and DIZZINESS (Dizzy) had not resolved and ILLNESS (Extremely sick), FEELING ABNORMAL (Felt like pulling brain out/felt like going to die), HYPOKINESIA (could not get up), MEMORY IMPAIRMENT (memory was gone), FALL (fell down) and the last episode of BACK PAIN (Back pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported.  Treatment medicine include Loratadine  Action taken with mRNA-1273 in response to the event was unknown
4cm erythema (mild) & induration surrounding inject site when pt seen 3-4 hrs p/inject; pt was able to walk w/o limp;
Bleeding from 2nd injection site for hours.; This is a spontaneous report from a contactable consumer (patient). A 45-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in left arm on 23Sep2021 20:30 (at the age of 45-year-old) (Lot Number: FC3184) as dose 2, single for COVID-19 immunization. The patient was not pregnant at the time of vaccination. Medical history included low iron; borderline diabetic in 1990s and allergy to latex bandages & fruits strawberries, figs. Concomitant medication(s) included fexofenadine hydrochloride (ALLEGRA) taken for hypersensitivity, start and stop date were not reported; cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) taken for hypersensitivity, start and stop date were not reported. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in left arm on 01Sep2021 13:15 (at the age of 45-year-old) (Lot Number: FC3184) as dose 1, single for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19. The patient experienced bleeding from 2nd injection site for hours on 23Sep2021 20:45. The patient did not receive treatment for the event. The outcome of event was unknown.  Follow-up attempts are completed. No further information is expected.
After the vaccination I experienced severe fatigue the day of and the next day after the vaccination. Nausea and dizziness was also experienced. I also had body aches.
Welt and swelling at the injection site bigger than a quarter; Swelling at the injection site bigger than a quarter; Redness in big circle at injection site; Injection site was very itchy; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the left arm on 27Apr2021 at 10:00 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included COPD and hypertension; both from an unknown date. The patient did not receive any medication within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7533) via an unspecified route of administration in the left arm on 30Mar2021 at 10:00 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Apr2021 at 11:00, the patient experienced welt and swelling at the injection site bigger than a quarter, redness in big circle at injection site and injection site very itchy. The clinical outcome of the events welt and swelling at the injection site bigger than a quarter, redness in big circle at injection site and injection site very itchy was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
I started itching at the injection site, my right deltoid. It had a big red whelp about the size of a fifty cent piece. The site was warm to the touch and raised. I started itching on my forehead and scalp then my arms and legs. Sxs lasted x 3-4 days. I continued taking CLARITIN until it stopped. At the time the reaction occurred I was working as an LPN in our Pediatric Convenient Care. NP gave me a dose of liquid steroid and CLARITIN. The meds really helped.
G62.9 NEUROPATHY 4/11/2023 THYROID CANCER
This case was reported by a other health professional via call center representative and described the occurrence of suspected vaccination failure in a 28-year-old female patient who received HAVRIX (batch number 4H37Y, expiry date 8th November 2020) for prophylaxis. On 20th June 2018, the patient received the 1st dose of HAVRIX. On an unknown date, less than a year after receiving HAVRIX, the patient experienced vaccination failure (serious criteria GSK medically significant) and hepatitis A. On an unknown date, the outcome of the vaccination failure and hepatitis A were unknown. It was unknown if the reporter considered the vaccination failure and hepatitis A to be related to HAVRIX. Additional details were provided as follows: The age at vaccination was not reported. The healthcare professional (HCP) reported that the patient received HAVRIX and after having labs drawn tested positive for hepatitis A. No further information was reported. This case was considered as suspected vaccination failure as time to onset for the event and details regarding vaccination schedule were unknown. The batch number reported for HAVRIX (4H374) did not exist and was updated to 4H37Y, as per sales database.
hives/broke out in hives; This is a spontaneous report received from a contactable consumer (reporting on himself) via Pfizer Sponsored Program COVAX US Support. A 59-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number and Expiry date not reported), via an unspecified route of administration on Mar2021, as single dose for COVID-19 immunization. The patient medical history concomitant medications were not reported. It was reported that patient received first dose of the Covid vaccine two weeks ago (on Mar2021). And reports 3 days after administration of the first dose, he had hives/broke out in hives, They went away quickly, gone after 1.5-2 days. Patient asked if he can get the second dose. He wants to know if this was part of the normal reaction to the vaccine and was asking what is the difference between immediate reactions and adverse reactions. The outcome of the event was recovered on an unspecified date.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Neck pain; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (Neck pain) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NECK PAIN (Neck pain). At the time of the report, NECK PAIN (Neck pain) outcome was unknown.            No concomitant medications reported by the reporter No treatment medications reported by the reporter